Oncology Advance

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Oncology Advance
Nov 11, 2024, 15:16 | Insight
Updated survival outcome of regorafenib, ipilimumab, and nivolumab in refractory MSS metastatic colorectal cancer
Arndt Vogel, Managing Senior Consultant at Hannover Medical School, shared an article by Annie Xiao…
Nov 4, 2024, 15:21 | Insight
ctDNA shines a light on MRD in colorectal cancer - Oncology Advance
Oncology Advance shared a post on X about a recent paper by Huu-Thinh Nguyen et…
Jul 17, 2024, 14:19 | Opinion
Essential read for advancing rare disease management - Oncology Advance
Oncology Advance shared on X: "Maximizing rare disease research impact requires economic principles. Key strategies:…
Jul 17, 2024, 12:35 | Insight
Aleix Prat: Our review article about HR+ breast cancer in young women
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Jun 19, 2024, 12:19 | Blog
Oncology Advance - See this month’s highlights from the ESMO portfolio
Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…
Mar 28, 2024, 02:42 | Insight
Jacob J. Adashek: If it’s a target, it’s a pan-cancer target: Tissue is not the issue
Jacob J. Adashek, Medical Oncology fellow at Johns Hopkins Kimmel Cancer Center, shared a post on…
Nov 11, 2023, 17:44 | Blog
Kari Leung: Our systematic review on quality indicators used to assess how systemic anticancer therapies are delivered
Kari Leung, Specialist Oncology Pharmacist at Guy's and St Thomas'​ NHS Foundation Trust, recently shared…
All: 7 Posts: 1 - 100
Special Coverage